Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : KCAP - Key Capital Corporation -- Ignore unavailable to you. Want to Upgrade?

To: ACC who wrote (18)	6/15/1998 8:09:00 PM
From: seminole	Respond to of 459

ACC I was lead over here from the ENMD site. Investing in biotech/small drug companies is a very risky. I believe you must follow both the science and finance of these companies. I am in the process of follow a conventional (toxin) cancer drug through clinical trials. I use journal publications and abstracts at the Am. Association of Cancer Researchers and Am. Association of Clinical Oncologist as my performance markers for the drug's progress. If I don't see the science referenced, I don't believe it. good luck richard

To: ACC who wrote (18)	6/15/1998 10:24:00 PM
From: zgoodman	Read Replies (2) \| Respond to of 459

ACC... I must say that I am very impressed with that Entrez browser you linked to. I too, found Urban's articles, though I'm afraid that my understanding of such things does come close to your own or the previous poster's (richard). Having said that, I was curious and called KCAP's IR dept. - They told me that for the type of information I was after, it would be best to talk with Dr. Urban. They had previously given Dr. Urban's phone number to me, so I called his service and he got back to me a few hours later, and told me this: Most of the research he was involved with has not been published. The reason for this? The research and subsequent production was privately-funded. Urban further noted that much of what does exist in the public domain is incorrectly documented. The description should be as follows: A nucleoprotein particle that produces a natural cascade immune response in the individual. It's all greek to me, but he did say that if anyone had some (intelligent) questions, that he would endeavor to contact the interested parties. Feel free to contact me privately for that number... or the KCAP IR dept. at 1-888-823-5767 Zack